Chondrocyte secreted CRTAC1:: A glycosylated extracellular matrix molecule of human articular cartilage

被引:63
作者
Steck, Eric
Braeun, Jessica
Pelttari, Karoliina
Kadel, Stephanie
Kalbacher, Hubert
Richter, Wiltrud
机构
[1] Heidelberg Univ, Stiftung Orthopad Klin, Sekt Expt Orthopad, Div Expt Orthopaed, D-69118 Heidelberg, Germany
[2] Univ Tubingen, Inst Physiol Chem, D-72074 Tubingen, Germany
关键词
CRTAC1; glycosyleation; extracellular matrix molecule; alternative splicing;
D O I
10.1016/j.matbio.2006.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cartilage acidic protein 1 (CRTAC1), a novel human marker which allowed discrimination of human chondrocytes from osteoblasts and mesenchymal stem cells in culture was so far studied only on the RNA-level. We here describe its genomic organisation and detect a new brain expressed (CRTAC1-B) isoform resulting from alternate last exon usage which is highly conserved in vertebrates. In humans, we identify an exon sharing process with the neighbouring tail-to-tail orientated gene leading to CRTAC1-A. This isoform is produced by cultured human chondrocytes, localized in the extracellular matrix of articular cartilage and its secretion can be stimulated by BMP4. Of five putative O-glycosylation motifs in the last exon of CRTAC1-A, the most C-terminal one is modified according to exposure of serial C-terminal deletion mutants to the O-glycosylation inhibitor Benzyl-alpha-GalNAc. Both isoforms contain four FG-GAP repeat domains and an RGD integrin binding motif, suggesting cell-cell or cell-matrix interaction potential. In summary, CRTAC1 acquired an alternate last exon from the tail-to-tail oriented neighbouring gene in humans resulting in the glycosylated isoform CRTAC1-A which represents a new extracellular matrix molecule of articular cartilage. (c) 2006 Elsevier B.V./International Society of Matrix Biology. All rights reserved.
引用
收藏
页码:30 / 41
页数:12
相关论文
共 31 条
[1]  
Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI [10.1093/nar/gkr1065, 10.1093/nar/gkp985, 10.1093/nar/gkh121]
[2]   Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes [J].
Benz, K ;
Breit, S ;
Lukoschek, M ;
Mau, H ;
Richter, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) :284-292
[3]   VAMP-1 has a highly variable C-terminus generated by alternative splicing [J].
Berglund, L ;
Hoffmann, HJ ;
Dahl, R ;
Petersen, TE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) :777-780
[4]  
Chan WC, 2000, PRACT APPROACH SER, V222, P41
[5]   Aspartyl β-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin [J].
Dinchuk, JE ;
Henderson, NL ;
Burn, TC ;
Huber, R ;
Ho, SP ;
Link, J ;
O'Neil, KT ;
Focht, RJ ;
Scully, MS ;
Hollis, JM ;
Hollis, GF ;
Friedman, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39543-39554
[6]  
DOEGE KJ, 1991, J BIOL CHEM, V266, P894
[7]   The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans [J].
Dzhambazov, B ;
Holmdahl, M ;
Yamada, H ;
Lu, SM ;
Vestberg, M ;
Holm, B ;
Johnell, O ;
Kihlberg, J ;
Holmdahl, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (02) :357-366
[8]   GalNAc-α-O-benzyl inhibits NeuAcα2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells [J].
Huet, G ;
Hennebicq-Reig, S ;
de Bolos, C ;
Ulloa, F ;
Lesuffleur, T ;
Barbat, A ;
Carrière, V ;
Kim, I ;
Real, FX ;
Delannoy, P ;
Zweibaum, A .
JOURNAL OF CELL BIOLOGY, 1998, 141 (06) :1311-1322
[9]   INTEGRINS - A FAMILY OF CELL-SURFACE RECEPTORS [J].
HYNES, RO .
CELL, 1987, 48 (04) :549-554
[10]   CHARACTERIZATION OF A BOVINE SYNOVIAL-FLUID LUBRICATING FACTOR .1. CHEMICAL, SURFACE-ACTIVITY AND LUBRICATING PROPERTIES [J].
JAY, GD .
CONNECTIVE TISSUE RESEARCH, 1992, 28 (1-2) :71-88